Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

BACKGROUND & AIMS:<br>The enhanced liver fibrosis (ELF) test has been proposed for the non-invasive assessment of advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). We performed a systematic review to estimate the accuracy of this test against biopsy. <br>&...

Full description

Bibliographic Details
Main Authors:	Vali, V, Lee, J, Boursier, J, Spijker, R, Löffler, J, Verheij, J, Brosnan, MJ, Böcskei, Z, Anstee, QM, Bossuyt, PM, Zafarmand, MH, Pavlides, M, LITMUS systematic review team(†)
Format:	Journal article
Language:	English
Published:	Elsevier 2020

Similar Items

Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy?
by: Chin, J, et al.
Published: (2016)

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
by: Mózes, FE, et al.
Published: (2021)

Volumetric analysis of liver fibrosis.
by: Leong, Yong Shin.
Published: (2013)

CD4+ T cells mediate the development of liver fibrosis in high fat diet-induced NAFLD in humanized mice
by: Her, Zhisheng, et al.
Published: (2020)

Quantitative histopathological assessment of liver fibrosis
by: Wojciechowska, M
Published: (2023)

The bone marrow functionally contributes to liver fibrosis.
by: Russo, F, et al.
Published: (2006)

Pituitary and testicular fibrosis in association with retroperitoneal fibrosis.
by: Grossman, A, et al.
Published: (1980)

Toward surface quantification of liver fibrosis progression
by: He, Yuting, et al.
Published: (2011)

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers
by: Gangadharan, B, et al.
Published: (2016)

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers
by: Gangadharan, B, et al.
Published: (2016)

Interobserver variability in histologic evaluation of liver fibrosis using categorical and quantitative scores
by: Pavlides, M, et al.
Published: (2017)

Molecular MRI of collagen to diagnose and stage liver fibrosis
by: Fuchs, Bryan C., et al.
Published: (2016)

Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis
by: Selvaraj, EA, et al.
Published: (2021)

Effect of micro-RNA 150 and 885 on liver fibrosis
by: Ali, Ashik
Published: (2019)

Structural characterization of liver fibrosis in magnetic resonance images
by: Szilágyi, A
Published: (2014)

Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease
by: Eddowes, P, et al.
Published: (2019)

Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs
by: Golder, Matthew R, et al.
Published: (2020)

Ultra-high-field MR-spectroscopy in NAFLD: novel mechanistic and diagnostic insights of energy metabolism in NASH and advanced fibrosis
by: Traussnigg, S, et al.
Published: (2017)

Deep learning enables automated scoring of liver fibrosis stages
by: Yu, Yang, et al.
Published: (2019)

Cardiac fibrosis and arrhythmogenesis
by: Nguyen, M, et al.
Published: (2017)

Intensity normalization of two-photon microscopy images for liver fibrosis analysis
by: Singh, Vijay Raj, et al.
Published: (2019)

Discovery and quantitation of novel liver fibrosis biomarkers in hepatitis C patients
by: Gangadharan, B
Published: (2017)

Targeting hepatic oxidative stress rescues bone loss in liver fibrosis
by: Sonoda, Soichiro, et al.
Published: (2022)

Novel serum biomarker candidates for liver fibrosis in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2007)

Discovery of new liver fibrosis markers in hepatitis C patients using proteomics
by: Gangadharan, B, et al.
Published: (2011)

Reply to: non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back?
by: Pavlides, M, et al.
Published: (2021)

Age-related atrial fibrosis.
by: Gramley, F, et al.
Published: (2009)

Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways
by: Chotirmall, Sanjay Haresh, et al.
Published: (2017)

Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
by: Veselu, D-F, et al.
Published: (2024)

Hepatic steatosis and fibrosis: Non-invasive assessment.
by: Karanjia, RN, et al.
Published: (2016)

Non-invasive imaging for the assessment of dermal fibrosis
by: Jones, H, et al.
Published: (2010)

NON-INVASIVE IMAGING FOR THE ASSESSMENT OF DERMAL FIBROSIS
by: Jones, H, et al.
Published: (2010)

The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)
by: Savic, D, et al.
Published: (2020)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2011)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2011)

Computer-aided-diagnosis of liver fibrosis using non-linear optics microscopy
by: Xu, Shuoyu
Published: (2015)

PTH-092 Discovery and quantitation of novel liver fibrosis biomarkers using proteomics
by: Gangadharan, B, et al.
Published: (2015)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients using proteomics
by: Gangadharan, B, et al.
Published: (2014)

Cystic Fibrosis in Malaysian Children
by: Norzila, M.Z., et al.
Published: (2005)

Myocardial fibrosis in aortic stenosis
by: Neubauer, S, et al.
Published: (2016)